Beijing, China

Chaojie Dang

USPTO Granted Patents = 5 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
5 patents (USPTO):

Title: An Insight into the Innovations of Chaojie Dang

Introduction

Chaojie Dang is a distinguished inventor based in Beijing, China, known for his significant contributions to the field of biomedicine. With a robust portfolio that includes five patents, his work is primarily focused on the development of innovative therapies targeting KRAS mutant proteins, a critical area of research in cancer treatment.

Latest Patents

Among Chaojie Dang's latest innovations are his patents related to KRAS mutant protein inhibitors. This invention outlines a KRAS mutant protein inhibitor characterized by a specific chemical formula (I). The invention includes a composition containing this inhibitor and explores its potential applications in medical therapy. The development of such inhibitors plays a vital role in advancing treatment options for patients with KRAS-driven cancers.

Career Highlights

Chaojie Dang is currently affiliated with Jacobio Pharmaceuticals Co., Ltd., a leading biopharmaceutical company renowned for its commitment to discovering and developing innovative medicines. His work at Jacobio has been pivotal in pushing the boundaries of cancer research and treatment, exemplifying his dedication to improving patient outcomes through scientific innovation.

Collaborations

Throughout his career, Chaojie has collaborated with several noteworthy individuals in the field, including his coworkers Amin Li and Sujing Li. These collaborations have fostered a dynamic environment for research and development, allowing for the pooling of expertise and resources to drive forward innovative solutions in medicinal chemistry.

Conclusion

Chaojie Dang stands out as a prominent figure in the realm of biomedical innovation. His numerous patents and ongoing research efforts reflect a commitment to addressing significant medical challenges. As he continues his work at Jacobio Pharmaceuticals, the impact of his inventions will undoubtedly contribute to the evolving landscape of cancer treatment and therapeutic interventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…